Cloning And Mutagenesis Global Market Is Expected To Grow At A Rate Of More Than 19% Through 2023 – 2027
26 Jul, 2023
The global cloning and mutagenesis market size is expected to grow from $2.09 billion in 2022 to $2.53 billion in 2023 at a compound annual growth rate (CAGR) of 21%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global cloning and mutagenesis market size is expected to reach $5.12 billion in 2027 at a CAGR of 19.3%.
Global Cloning And Mutagenesis Market Key Driver
Rising demand for genetically modified products is projected to drive the cloning and mutagenesis industry ahead in the coming years. Any organism, material, or substance that has been genetically modified via deliberate alteration of an organism's genes to introduce new features or characteristics is referred to as a genetically modified product. Cloning is a scientific technique that produces exact genetic clones for various living species that are resistant to insects and plants, as well as in medical sciences for gene therapy, therefore the increasing demand for genetically modified items will promote the expansion of the cloning and mutagenesis industry.
Get a sample of the global cloning and mutagenesis market reportGlobal Cloning And Mutagenesis Market Segments
The global cloning and mutagenesis market is segmented:
1) By Product: Cloning Kits, Mutagenesis Kits, Other Product
2) By Technique: Blunt End Cloning, Topo PCR Cloning, Seamless Cloning, Site-Directed Mutagenesis, Other Techniques
3) By End User: Academic and Research Institutes, Biotechnology Companies, Other End User
4) By Geography: The regions covered in the cloning and mutagenesis market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions, North America accounts for the largest share in the global cloning and mutagenesis market.
Major Cloning And Mutagenesis Industry Players
Thermo Fisher Scientific, Takara Bio Inc., Agilent Technologies Inc., Jena Bioscience GmbH, Transgen Biotech Co, New England Biolabs, Merck KGaA, Promega Corporation, Bio-Rad Laboratories Inc., Danaher, Assay Genie, Genomax Technologies Pte Ltd, GENEWIZ Inc., abm Inc., GenScript, EZBioscience, Codex DNA Inc.
Get the full global cloning and mutagenesis market report
Cloning And Mutagenesis Market Overview
Cloning and mutagenesis refer to interrelated techniques of molecular biology that consist of making multiple identical copies of a DNA fragment, gene, or entire genome, and mutations into a DNA sequence. Cloning and mutagenesis are used to study gene function and regulation, develop new drugs and therapeutics, and develop recombinant enzymes and proteins.
Cloning And Mutagenesis Global Market Report 2023 provides data on the global cloning and mutagenesis market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The cloning and mutagenesis market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.